As of 2025-06-13, the Fair Value of Myriad Genetics Inc (MYGN) is -5.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.19 USD, the upside of Myriad Genetics Inc is -205.97%.
With the market price of 5.19 USD and our fair value calculation, Myriad Genetics Inc (MYGN) is not a good investment. Investing in MYGN stocks now will result in a potential loss of 205.97%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -53.10 | -27.20 | -112.00 | -263.30 | -127.30 | -116.58 |
| YoY growth | 73.38% | 48.78% | -311.76% | -135.09% | 51.65% | -54.61% |
| Market Cap (mil) | 478.41 |
| P/E | |
| Forward P/E |
| EPS | -1.10 |
| Avg earnings growth rate | -54.61% |
| TTM earnings | -101.40 |